Lessons from the Frontlines: How a Louisville Lab Used the ARIES® System to Respond to the COVID-19 Pandemic

The sample-to-answer platform delivered timely and accurate test results during a critical time As COVID-19 began to spread in early 2020, scientists and medical professionals across the world began quickly responding to community needs, shifting priorities to help understand and address the pandemic. At this year’s Association for Molecular Pathology (AMP) annual meeting, we hosted [Read More…]

The Year in Review—How COVID-19 Transformed Our World

Reflecting on a challenging year in global health As 2021 inches closer, many of us have begun our annual reflection, reviewing the events of the past year to gain perspective, and shape the months ahead. Ordinarily, one might identify several themes that characterized the year—but in 2020, everything was filtered through the lens of the [Read More…]

Bracing for Flu Season in a Pandemic World

How clinical laboratories can prepare as COVID-19 meets influenza It’s officially autumn in the United States, which means pumpkin picking, college football, and, of course, the start of flu season. This annual occurrence is always a challenge for clinical laboratories, but this year, circulation of the influenza virus coincides with the ongoing COVID-19 pandemic, creating a [Read More…]

Webinar: Mount Sinai Scientists Design Multiplex COVID-19 Antibody Test

Implementing xMAP® Technology allows for faster, more accurate results When the global outbreak hit the US, the Icahn School of Medicine at Mount Sinai in New York City published some of the earliest COVID-19 studies in the US. It’s no surprise then that scientists at Mount Sinai were among the first to develop an antibody test. [Read More…]

Coming Soon: A New Multiplex Serology Test for SARS-CoV-2

Luminex Partner Tetracore designed a serology assay for SARS-CoV-2 using xMAP® Technology. A new multiplex serology test to determine whether someone has been exposed to the SARS-CoV-2 virus is coming soon, thanks to assay developer Tetracore. The company—one of Luminex’s research partners—developed this test based on our xMAP Technology. We spoke with Tetracore Senior Scientist [Read More…]

In Germany, Screening for COVID-19 with the ARIES® System

Clinical lab scientist describes his experience establishing a two-step diagnostic algorithm for COVID-19 Scientists in clinical labs worldwide have worked night and day in the COVID-19 pandemic to develop, validate, and implement new diagnostic tests for patients believed to be infected by the SARS-CoV-2 virus. While each lab’s experiences are slightly different, there are certain [Read More…]

Luminex’s Flexible SARS-CoV-2 Assays Enable Both High-Throughput and Emergency Testing

Federal funding and FDA Emergency Use Authorization streamlined development and commercialization of these new assays. As the COVID-19 pandemic swept across the globe, people everywhere have raced to respond. The Luminex team has been working around the clock on much-needed molecular diagnostic assays for the SARS-CoV-2 virus, two of which recently received Emergency Use Authorization [Read More…]

How Luminex Is Supporting Research Partners’ Pandemic Response

Licensed Technologies Group is finding new ways to boost partner programs Here at Luminex, we are working on all fronts to help fight the coronavirus pandemic. The most visible activities have been the launch of new diagnostic tests—namely, the NxTAG® CoV Extended Panel and the ARIES® SARS-CoV-2 Assay—both of which received Emergency Use Authorization from [Read More…]